# A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

> **NCT01742585** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 163 (actual)

## Conditions studied

- Chronic Kidney Disease
- Renal Insufficiency
- Hyperphosphatemia

## Interventions

- **DRUG:** ASP1585
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01742585
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2014-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01742585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01742585, "A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01742585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*